Severe myelopathy after denture cream use - Is copper deficiency or excess zinc the cause?

Funding

Dr. Zittel has received research support by the Wegener Stiftung and Merz Pharmaceuticals. Dr. Ufer reports no disclosures. Dr. Gerloff was supported by advisory Boards of Boehringer Ingelheim and Silk Road Medical, and by grants from the DFG (Ge 844/2-1, Ge 844/4-1), the Bundesministerium für Bildung und Forschung (BMBF competence net stroke, BMBF Multicare), and UKE intramural grants. Dr. Münchau received commercial research support from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline and Desitin. He is supported by the following non-profit foundations or societies: Possehl-Stiftung, Lübeck, Dystonia Coalition (USA), Tourette Syndrome Association (Germany), European Huntington Disease Network, N.E.MO., a charity supporting the research of paediatric movement disorders. He receives academic research support form the Deutsche Forschungsgemeinschaft (MU 1692/3-1; SFB 936) and the University of Lübeck. He is employed at the University of Lübeck. Dr. Rosenkranz has received speaker honoraria from Boehringer-Ingelheim, Pfizer Pharma, Bristol-Myers Squibb, Bayer Healthcare, GlaxoSmithKline and from Bracco, funding for travel from Boehringer-Ingelheim, and funding for travel from the German Research Foundation (DFG), and was supported by UKE intramural grants. Appendix A